Giuseppe Remuzzi, M.D. – Bergamo, Italy

Currently Professor of Nephrology and Coordinator of the Department of Medicine and Transplantation of the Ospedali Riuniti di Bergamo, Italy and Director of the Division of Nephrology and Dialysis of the same hospital.

He also directs the Negri Bergamo Laboratories of the Mario Negri Institute for Pharmacological Research, a unique group of basic scientists and clinicians devoted to the study of renal disease, with particular focus on platelet endothelial interactions, vascular prostaglandin biology, coagulation and renal disease, progression of renal disease, experimental models of glomerular damage, and transplant immunology and tolerance. Particularly far-reaching are his contributions to our understanding of the pathophysiology of hemolytic uremic syndrome, prostaglandin metabolism in pregnancy, renal vascular biology in uremia, the role of protein trafficking in renal disease progression, the induction of graft tolerance by intrathymic injection of donor antigens, and the role of the co-stimulatory CD28-B67 pathway in transplant rejection and the prevention of renal and cardiovascular damage in diabetes.

Prof. Remuzzi serves on editorial boards of numerous journals including the prestigious New England Journal of Medicine and is member of the International Advisory Board of The Lancet.

In recognition of his achievements, he has been awarded in 1998 honorary memberships in the Association of American Physicians and the British Royal Society of Physicians.

In 2005 during the World Congress of Nephrology in Singapore he received the ISN Jean Hamburger Award.

Prof. Remuzzi has authored and co-authored more than 850 scientific articles, reviews and monographs.